Alexis Borisy, IDRx co-founder
New biotech from Alexis Borisy will test Merck KGaA, Blueprint cancer drug combo in bid to fulfill Gleevec promise
Alexis Borisy and Ben Auspitz want to be intelligent with their latest biotech, not “stupid.”
That’s in the words of Borisy, the repeat biotech entrepreneur …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
